Allied Market Research

2024

Cholesterol Screening Market

Cholesterol Screening Market Size, Share, Competitive Landscape and Trend Analysis Report by End Users (Physicians/Providers, Hospitals, Managed Care Organizations (MCOs), Government Agencies, Accountable Care Organizations (ACOs), Integrated Delivery Networks (IDNs)): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

The elevated levels of cholesterol create health threats such as sharp risk of stroke & heart diseases and account for a large number of deaths. Cholesterol screening services allow early detection of the problems related to high cholesterol levels, avoiding complications and increasing the survival chances of patients.

The major factors that fuel the market growth include increase in incidence of cardiovascular diseases, sedentary lifestyle, rise in geriatric population offering a large patient pool, and government initiatives for better healthcare services. Furthermore, increase in healthcare expenditure and rise in public awareness about the cardiovascular disease, its causes, treatment, and prevention also boost the growth of the market. However, swift growth in self-testing devices and the advent of noninvasive cholesterol testing approaches hamper the growth of the market.

The global cholesterol screening market is segmented on the basis of end users and region. On the basis of end-users, it is divided into Physicians/Providers, Hospitals, Managed Care Organizations (MCOs), Government Agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs). By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies profiled in this report include ACM Medical Laboratory, Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific, Quest Diagnostics Incorporated, SYNLAB International GmbH, Fresenius Medical Care Holdings, Inc.

Key Benefits

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by type assists in understanding the regional trends.
  • Key players and their strategies are analyzed to understand the competitive outlook of the market.

Cholesterol Screening Market Report Highlights

Aspects Details
Cholesterol Screening Market By End Users
By End Users
  • Physicians/Providers
  • Hospitals
  • Managed Care Organizations (MCOs)
  • Government Agencies
  • Accountable Care Organizations (ACOs)
  • Integrated Delivery Networks (IDNs)
Cholesterol Screening Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Fresenius Medical Care Holdings, Inc., Quest Diagnostics Incorporated, Eurofins Scientific, Clinical Reference Laboratory, Inc., Spectra Laboratories Inc., Laboratory Corporation of America Holdings, ACM Medical Laboratory, Bio-Reference Laboratories Inc., SYNLAB International GmbH, Unilabs

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Cholesterol Screening Market

Global Opportunity Analysis and Industry Forecast, 2023-2032